January 15, 2025

Bertagnolli to Exit NIH Director Role

NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.

Conexiant

January 15, 2025

CMR-PCWP Correlates with Heart Failure Biomarkers

In HFrEF patients, cardiovascular magnetic resonance-estimated pulmonary capillary wedge pressure "correlates with clinical and ultrasound markers of congestion," demonstrates potential as a non-invasive alternative to traditional pressure measurements.

Conexiant

January 13, 2025

Transcatheter Valve Replacement: Key 1-Year Outcomes

Transcatheter tricuspid-valve replacement reduced tricuspid regurgitation to a level that is mild or less in 95% of patients, with associated improvements in quality of life, functional capacity, and survival compared to medical therapy.

Conexiant

January 09, 2025

Study: Aspirin Shields SLE Patients from ASCVD

A recent study has linked antiphospholipid antibodies to atherosclerotic cardiovascular disease in systemic lupus erythematosus patients, highlighting the potential of aspirin to reduce risk. Source: BMC Medicine

Conexiant

January 08, 2025

J&J Pauses U.S. Heart Device Rollout

Johnson & Johnson pauses Varipulse heart device rollout in the U.S. after reported stroke events, affecting their stock value.

Reuters

January 06, 2025

Why UFH Still Dominates in PE Care

Discover key factors influencing anticoagulant choice in hospitalized pulmonary embolism patients and strategies to improve guideline adherence.

Conexiant

December 30, 2024

Light Wine Consumption May Cut CVD Risk in Half

"It is critical to note that the study’s findings reinforce the notion that these cardiovascular benefits are limited to moderate wine consumption."

Conexiant

April 21, 2023

Impact of tricuspid valve regurgitation on intermediate outcomes of degenerative mitral valve surgery

Watch Juan A. Crestanello, M.D., discuss the impact of tricuspid valve regurgitation on intermediate outcomes of degenerative mitral valve surgery.

Mayo Clinic

February 14, 2024

Top-Ranked Smidt Heart Institute at Cedars-Sinai Releases 2024 Annual Report

The Smidt Heart Institute continues to break new ground in cardiovascular research and care. It is a global leader in heart transplants, women's heart disease, targeted therapies, and a suite of minimally invasive procedures.

Cedars-Sinai Pulse